U1 Bio, Inc. — Form D
U1 Bio, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-06-08. The offering totals $10.7M, of which $9.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-06-08
- Form: D
- Accession: 0001850995-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.7M
- Amount sold: $9.5M
- Remaining: $1.2M
- Minimum investment: $25K
- Investors: 26
- Date of first sale: 2022-05-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-448526
Issuer
- Name: U1 Bio, Inc.
- CIK: 0001850995
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 18 BARTOL STREET #966, SAN FRANCISCO, CA, 94133
- Phone: (336) 420-7881
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Konstantinos Charizanis | Director | San Francisco, CA |
| David Nelles | Director | San Francisco, CA |
| Sharam Seyedin-Noor | Director | Belvedere Tiburon, CA |
| Konstantinos Charizanis | Executive Officer | San Francisco, CA |
| David Nelles | Executive Officer | San Francisco, CA |
Other filings by this issuer (1)
More